GENEVA, Sept. 18 -- HALOZYME, INC. filed a patent application (US2025/045674) for “COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES AND HYALURONIDASES”. With publication no. WO/2026/187389, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/47
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....